News & Updates
Posted On: January 4, 2022 Rye Brook, N.Y., January 4, 2022 – Given the rapid rise in COVID-19 infections caused by the Omicron variant, The Leukemia & L Read More
Posted On: December 22, 2021 Rye Brook, N.Y., December 15, 2021 – The Food and Drug Administration (FDA) recently approved abatacept (Orencia), in combination Read More
Largest Study to Date Demonstrates Most Blood Cancer Patients Benefit From a Third Primary Dose of mRNA COVID-19 VaccinePosted On: December 13, 2021 Study supports the Centers for Disease Control and Prevention (CDC) recommendation for immunocompromised adults Read More
Information and support on the web, on the phone, and from real people in your community.
Fundraise for LLS
Make an impact in the fight to cure cancer.